EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances and challenges in Helicobacter pylori subunit vaccine development: antigen candidates and immunization strategies

Zhili Liu, He Li, Xiaotian Huang, Qiong Liu

Journal of Applied Microbiology · 06.10.2025 · 136 (10)

DOI: 10.1093/jambio/lxaf236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Applied Microbiology, online erschienen am 22.09.2025. Verfasst von Zhili Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Bacterial Vaccines, Antigens, Bacterial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 157 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Youth.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori, which infects nearly half of the global population, is a major cause of gastrointestinal diseases, including peptic ulcers, gastric cancer, and lymphoma. Current treatment regimens are hampered by antibiotic resistance, high costs, and adverse side effects, highlighting the urgent need for effective vaccines. Several subunit vaccines have demonstrated promising protection or clearance rates in preclinical experiments using animal models, providing a strong rationale for advancing H. pylori vaccines into human clinical trials. However, no vaccine has been commercialized to date, with only the UreB vaccine progressing to Phase III clinical trials. This review discusses recent progress, challenges, and prospects in the development of H. pylori subunit vaccines, with emphasis on antigen selection, adjuvants, immunization strategies, and delivery systems. By evaluating key antigenic candidates and their immunogenic properties, this article aims to provide a comprehensive overview to inform future vaccine development against H. pylori infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsBacterial VaccinesAntigens, BacterialVaccine DevelopmentVaccines, SubunitHumansAnimalsAdjuvants, ImmunologicImmunizationAdjuvants, Vaccine

Stichwörter der Autor:innen

Helicobacter pyloriantigenssubunit vaccine

Substanzen

Bacterial VaccinesVaccines, SubunitAntigens, BacterialAdjuvants, ImmunologicAdjuvants, Vaccine

Autor:innen und Institutionen

  • Department of Medical Microbiology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • HuanKui Academy, Nanchang University, Nanchang 330006, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangxi Province
  • Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Youth
  • Science and Technology Innovation in Jiangxi
  • National Innovation and Entrepreneurship

Zitieren

APA

Liu, Z., Li, H., Huang, X., & Liu, Q. (2025). Advances and challenges in Helicobacter pylori subunit vaccine development: antigen candidates and immunization strategies. Journal of Applied Microbiology, 136(10). https://doi.org/10.1093/jambio/lxaf236

Vancouver

Liu Z, Li H, Huang X, Liu Q. Advances and challenges in Helicobacter pylori subunit vaccine development: antigen candidates and immunization strategies. Journal of Applied Microbiology. 2025;136(10). doi:10.1093/jambio/lxaf236

BibTeX
@article{Liu2025,
  author = {Liu, Zhili and Li, He and Huang, Xiaotian and Liu, Qiong},
  title = {Advances and challenges in Helicobacter pylori subunit vaccine development: antigen candidates and immunization strategies},
  journal = {Journal of Applied Microbiology},
  year = {2025},
  volume = {136},
  number = {10},
  doi = {10.1093/jambio/lxaf236}
}
Kostenlos starten →